Denali Therapeutics (DNLI) Current Assets (2017 - 2026)
Denali Therapeutics (DNLI) recorded Current Assets of $753.93 million in Q2 2026, down 19.3% from $934.71 million a year earlier and down 26.3% from the prior quarter.
Denali Therapeutics (DNLI) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Denali Therapeutics reported Current Assets of $900.66 million, up 4.2% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of -9.6% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $864.44 million in FY2024 (-18.8%), $1.06 billion in FY2023 (-22.5%), $1.37 billion in FY2022 (+52.9%) and $897.23 million in FY2021 (-40.0%).
- The Q2 2026 figure is the lowest quarterly Current Assets since Q2 2020.
- On a year-over-year basis, Current Assets rose in four of the last eight quarters, with an average decline of 6.1%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 52.9% in Q4 2022, against a decline of 40.0% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.02 billion (Q1 2026), $900.66 million (Q4 2025) and $882.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Denali Therapeutics | 3.35 Bn | 3.35 Bn | 3.51 Mn | 753.93 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 753.93 Mn |
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 900.66 Mn |
| Sep 30, 2025 | 882.60 Mn |
| Jun 30, 2025 | 934.71 Mn |
| Mar 31, 2025 | 878.64 Mn |
| Dec 31, 2024 | 864.44 Mn |
| Sep 30, 2024 | 868.84 Mn |
| Jun 30, 2024 | 928.38 Mn |
| Mar 31, 2024 | 973.58 Mn |
| Dec 31, 2023 | 1.06 Bn |
| Sep 30, 2023 | 1.14 Bn |
| Jun 30, 2023 | 1.22 Bn |
| Mar 31, 2023 | 1.33 Bn |
| Dec 31, 2022 | 1.37 Bn |
| Sep 30, 2022 | 1.14 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 988.44 Mn |
| Dec 31, 2021 | 897.23 Mn |
| Sep 30, 2021 | 1.06 Bn |
Denali Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=DNLI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();